Listed

Vertex Pharmaceuticals Inc / Ma

VRTXNasdaqCIK 875320HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.33bn, Q2 FY2026
Operating income$1.25bn, Q2 FY2026
Net income$1.10bn, Q2 FY2026
Vertex Pharmaceuticals Inc / Ma, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m2,484Revenue, Q3 FY2023, three months to 2023-09-30$2.48bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure2,518Revenue, Q4 FY2023, three months to 2023-12-31$2.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure2,691Revenue, Q1 FY2024, three months to 2024-03-31$2.69bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure2,646Revenue, Q2 FY2024, three months to 2024-06-30$2.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure2,772Revenue, Q3 FY2024, three months to 2024-09-30$2.77bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure2,912Revenue, Q4 FY2024, three months to 2024-12-31$2.91bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure2,770Revenue, Q1 FY2025, three months to 2025-03-31$2.77bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure2,965Revenue, Q2 FY2025, three months to 2025-06-30$2.96bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure3,076Revenue, Q3 FY2025, three months to 2025-09-30$3.08bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure3,190Revenue, Q4 FY2025, three months to 2025-12-31$3.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure2,987Revenue, Q1 FY2026, three months to 2026-03-31$2.99bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure3,334Revenue, Q2 FY2026, three months to 2026-06-30$3.33bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Cost of revenue$m319Cost of revenue, Q3 FY2023, three months to 2023-09-30$318.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure368Cost of revenue, Q4 FY2023, three months to 2023-12-31$368.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure343Cost of revenue, Q1 FY2024, three months to 2024-03-31$342.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure372Cost of revenue, Q2 FY2024, three months to 2024-06-30$371.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure393Cost of revenue, Q3 FY2024, three months to 2024-09-30$392.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure423Cost of revenue, Q4 FY2024, three months to 2024-12-31$423.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure363Cost of revenue, Q1 FY2025, three months to 2025-03-31$363.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure408Cost of revenue, Q2 FY2025, three months to 2025-06-30$407.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure415Cost of revenue, Q3 FY2025, three months to 2025-09-30$414.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure466Cost of revenue, Q4 FY2025, three months to 2025-12-31$466.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure393Cost of revenue, Q1 FY2026, three months to 2026-03-31$392.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure489Cost of revenue, Q2 FY2026, three months to 2026-06-30$489.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m264Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$263.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure369Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$369.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure343Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$342.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure372Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$372.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure372Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$371.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure378Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$377.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure396Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$396.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure425Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$424.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure445Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$445.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure487Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$487.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure494Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$493.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure582Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$582.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Operating income$m1,038Operating income, Q3 FY2023, three months to 2023-09-30$1.04bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure989Operating income, Q4 FY2023, three months to 2023-12-31$988.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,140Operating income, Q1 FY2024, three months to 2024-03-31$1.14bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure(3,515)Operating income, Q2 FY2024, three months to 2024-06-30−$3.51bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure1,116Operating income, Q3 FY2024, three months to 2024-09-30$1.12bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure1,026Operating income, Q4 FY2024, three months to 2024-12-31$1.03bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure630Operating income, Q1 FY2025, three months to 2025-03-31$630.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,151Operating income, Q2 FY2025, three months to 2025-06-30$1.15bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure1,186Operating income, Q3 FY2025, three months to 2025-09-30$1.19bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure1,206Operating income, Q4 FY2025, three months to 2025-12-31$1.21bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,138Operating income, Q1 FY2026, three months to 2026-03-31$1.14bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,247Operating income, Q2 FY2026, three months to 2026-06-30$1.25bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Interest expense$m10.9Interest expense, Q3 FY2023, three months to 2023-09-30$10.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure10.6Interest expense, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure10.4Interest expense, Q1 FY2024, three months to 2024-03-31$10.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure9.9Interest expense, Q2 FY2024, three months to 2024-06-30$9.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure7.5Interest expense, Q3 FY2024, three months to 2024-09-30$7.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure2.8Interest expense, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure3.7Interest expense, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure3.3Interest expense, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure3.3Interest expense, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$m144Income tax, Q3 FY2023, three months to 2023-09-30$143.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure179Income tax, Q4 FY2023, three months to 2023-12-31$178.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure180Income tax, Q1 FY2024, three months to 2024-03-31$179.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure202Income tax, Q2 FY2024, three months to 2024-06-30$202.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure179Income tax, Q3 FY2024, three months to 2024-09-30$178.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure224Income tax, Q4 FY2024, three months to 2024-12-31$223.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure84.1Income tax, Q1 FY2025, three months to 2025-03-31$84.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure250Income tax, Q2 FY2025, three months to 2025-06-30$250.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure216Income tax, Q3 FY2025, three months to 2025-09-30$215.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure140Income tax, Q4 FY2025, three months to 2025-12-31$139.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure222Income tax, Q1 FY2026, three months to 2026-03-31$221.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure292Income tax, Q2 FY2026, three months to 2026-06-30$292.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Net income$m1,035Net income, Q3 FY2023, three months to 2023-09-30$1.04bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure969Net income, Q4 FY2023, three months to 2023-12-31$968.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,100Net income, Q1 FY2024, three months to 2024-03-31$1.10bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure(3,594)Net income, Q2 FY2024, three months to 2024-06-30−$3.59bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure1,045Net income, Q3 FY2024, three months to 2024-09-30$1.05bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure913Net income, Q4 FY2024, three months to 2024-12-31$913.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure646Net income, Q1 FY2025, three months to 2025-03-31$646.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,033Net income, Q2 FY2025, three months to 2025-06-30$1.03bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure1,083Net income, Q3 FY2025, three months to 2025-09-30$1.08bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure1,191Net income, Q4 FY2025, three months to 2025-12-31$1.19bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,031Net income, Q1 FY2026, three months to 2026-03-31$1.03bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,100Net income, Q2 FY2026, three months to 2026-06-30$1.10bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Diluted EPS$ per share3.97Diluted EPS, Q3 FY2023, three months to 2023-09-30$3.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figurenot reported4.21Diluted EPS, Q1 FY2024, three months to 2024-03-31$4.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure(13.92)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$13.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure4.01Diluted EPS, Q3 FY2024, three months to 2024-09-30$4.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figurenot reported2.49Diluted EPS, Q1 FY2025, three months to 2025-03-31$2.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure3.99Diluted EPS, Q2 FY2025, three months to 2025-06-30$3.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure4.20Diluted EPS, Q3 FY2025, three months to 2025-09-30$4.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figurenot reported4.02Diluted EPS, Q1 FY2026, three months to 2026-03-31$4.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure4.31Diluted EPS, Q2 FY2026, three months to 2026-06-30$4.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Basic EPS$ per share4.01Basic EPS, Q3 FY2023, three months to 2023-09-30$4.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figurenot reported4.26Basic EPS, Q1 FY2024, three months to 2024-03-31$4.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure(13.92)Basic EPS, Q2 FY2024, three months to 2024-06-30−$13.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure4.05Basic EPS, Q3 FY2024, three months to 2024-09-30$4.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figurenot reported2.52Basic EPS, Q1 FY2025, three months to 2025-03-31$2.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure4.02Basic EPS, Q2 FY2025, three months to 2025-06-30$4.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure4.24Basic EPS, Q3 FY2025, three months to 2025-09-30$4.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figurenot reported4.06Basic EPS, Q1 FY2026, three months to 2026-03-31$4.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure4.34Basic EPS, Q2 FY2026, three months to 2026-06-30$4.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure

Balance sheet

Cash and equivalents$6.14bn, Q2 FY2026
Shareholders' equity$20.25bn, Q2 FY2026
Vertex Pharmaceuticals Inc / Ma, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn11.1Cash and equivalents, Q3 FY2023, at 2023-09-30$11.11bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure10.4Cash and equivalents, FY2023, at 2023-12-31$10.37bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure9.2Cash and equivalents, Q1 FY2024, at 2024-03-31$9.16bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure4.6Cash and equivalents, Q2 FY2024, at 2024-06-30$4.58bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure5.2Cash and equivalents, Q3 FY2024, at 2024-09-30$5.24bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure4.6Cash and equivalents, FY2024, at 2024-12-31$4.57bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure4.7Cash and equivalents, Q1 FY2025, at 2025-03-31$4.67bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure5.0Cash and equivalents, Q2 FY2025, at 2025-06-30$4.97bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure4.9Cash and equivalents, Q3 FY2025, at 2025-09-30$4.94bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure5.1Cash and equivalents, FY2025, at 2025-12-31$5.08bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure5.5Cash and equivalents, Q1 FY2026, at 2026-03-31$5.49bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure6.1Cash and equivalents, Q2 FY2026, at 2026-06-30$6.14bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Current assets$bn14.7Current assets, Q3 FY2023, at 2023-09-30$14.70bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000875320-23-000031.Report this figure14.1Current assets, FY2023, at 2023-12-31$14.14bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-13, accession 0000875320-25-000053.Report this figure13.3Current assets, Q1 FY2024, at 2024-03-31$13.29bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000875320-24-000139.Report this figure8.9Current assets, Q2 FY2024, at 2024-06-30$8.94bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-02, accession 0000875320-24-000198.Report this figure9.8Current assets, Q3 FY2024, at 2024-09-30$9.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure9.6Current assets, FY2024, at 2024-12-31$9.60bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure10.0Current assets, Q1 FY2025, at 2025-03-31$10.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure10.4Current assets, Q2 FY2025, at 2025-06-30$10.43bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure10.6Current assets, Q3 FY2025, at 2025-09-30$10.57bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure11.2Current assets, FY2025, at 2025-12-31$11.20bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure11.7Current assets, Q1 FY2026, at 2026-03-31$11.73bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure12.5Current assets, Q2 FY2026, at 2026-06-30$12.54bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Total assets$bn21.7Total assets, Q3 FY2023, at 2023-09-30$21.73bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000875320-23-000031.Report this figure22.7Total assets, FY2023, at 2023-12-31$22.73bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-13, accession 0000875320-25-000053.Report this figure23.9Total assets, Q1 FY2024, at 2024-03-31$23.92bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000875320-24-000139.Report this figure20.1Total assets, Q2 FY2024, at 2024-06-30$20.13bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0000875320-24-000198.Report this figure22.2Total assets, Q3 FY2024, at 2024-09-30$22.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure22.5Total assets, FY2024, at 2024-12-31$22.53bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure22.9Total assets, Q1 FY2025, at 2025-03-31$22.88bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure24.0Total assets, Q2 FY2025, at 2025-06-30$24.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure24.9Total assets, Q3 FY2025, at 2025-09-30$24.86bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure25.6Total assets, FY2025, at 2025-12-31$25.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure26.5Total assets, Q1 FY2026, at 2026-03-31$26.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure27.4Total assets, Q2 FY2026, at 2026-06-30$27.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Current liabilities$bn3.6Current liabilities, Q3 FY2023, at 2023-09-30$3.60bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000875320-23-000031.Report this figure3.5Current liabilities, FY2023, at 2023-12-31$3.55bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-13, accession 0000875320-25-000053.Report this figure3.8Current liabilities, Q1 FY2024, at 2024-03-31$3.80bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000875320-24-000139.Report this figure3.5Current liabilities, Q2 FY2024, at 2024-06-30$3.55bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-02, accession 0000875320-24-000198.Report this figure4.0Current liabilities, Q3 FY2024, at 2024-09-30$3.97bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure3.6Current liabilities, FY2024, at 2024-12-31$3.56bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure3.8Current liabilities, Q1 FY2025, at 2025-03-31$3.78bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure4.1Current liabilities, Q2 FY2025, at 2025-06-30$4.14bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure4.5Current liabilities, Q3 FY2025, at 2025-09-30$4.48bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure3.9Current liabilities, FY2025, at 2025-12-31$3.86bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure3.9Current liabilities, Q1 FY2026, at 2026-03-31$3.88bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure3.9Current liabilities, Q2 FY2026, at 2026-06-30$3.94bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Total liabilities$bn5.2Total liabilities, Q3 FY2023, at 2023-09-30$5.21bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000875320-23-000031.Report this figure5.1Total liabilities, FY2023, at 2023-12-31$5.15bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-13, accession 0000875320-25-000053.Report this figure5.4Total liabilities, Q1 FY2024, at 2024-03-31$5.37bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000875320-24-000139.Report this figure5.4Total liabilities, Q2 FY2024, at 2024-06-30$5.36bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0000875320-24-000198.Report this figure6.6Total liabilities, Q3 FY2024, at 2024-09-30$6.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure6.1Total liabilities, FY2024, at 2024-12-31$6.12bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure6.4Total liabilities, Q1 FY2025, at 2025-03-31$6.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure6.9Total liabilities, Q2 FY2025, at 2025-06-30$6.86bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure7.5Total liabilities, Q3 FY2025, at 2025-09-30$7.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure7.0Total liabilities, FY2025, at 2025-12-31$6.98bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure7.1Total liabilities, Q1 FY2026, at 2026-03-31$7.12bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure7.2Total liabilities, Q2 FY2026, at 2026-06-30$7.18bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure
Long-term debt$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$bn16.5Shareholders' equity, Q3 FY2023, at 2023-09-30$16.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure17.6Shareholders' equity, FY2023, at 2023-12-31$17.58bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-13, accession 0000875320-26-000056.Report this figure18.5Shareholders' equity, Q1 FY2024, at 2024-03-31$18.55bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure14.8Shareholders' equity, Q2 FY2024, at 2024-06-30$14.77bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure15.6Shareholders' equity, Q3 FY2024, at 2024-09-30$15.63bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure16.4Shareholders' equity, FY2024, at 2024-12-31$16.41bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure16.5Shareholders' equity, Q1 FY2025, at 2025-03-31$16.50bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure17.2Shareholders' equity, Q2 FY2025, at 2025-06-30$17.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure17.3Shareholders' equity, Q3 FY2025, at 2025-09-30$17.32bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure18.7Shareholders' equity, FY2025, at 2025-12-31$18.67bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure19.4Shareholders' equity, Q1 FY2026, at 2026-03-31$19.36bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure20.2Shareholders' equity, Q2 FY2026, at 2026-06-30$20.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure

Cash flow

Operating cash flow$1.13bn, Q2 FY2026
Capital expenditure$112.2m, Q2 FY2026
Share repurchases$469.5m, Q2 FY2026
Vertex Pharmaceuticals Inc / Ma, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m1,268Operating cash flow, Q3 FY2023, three months to 2023-09-30$1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0000875320-24-000223. Derived: 9-month figure less the 6-month figure.Report this figure235Operating cash flow, Q4 FY2023, three months to 2023-12-31$234.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,307Operating cash flow, Q1 FY2024, three months to 2024-03-31$1.31bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure(3,754)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.75bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000875320-25-000216. Derived: 6-month figure less the 3-month figure.Report this figure1,370Operating cash flow, Q3 FY2024, three months to 2024-09-30$1.37bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure585Operating cash flow, Q4 FY2024, three months to 2024-12-31$584.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure819Operating cash flow, Q1 FY2025, three months to 2025-03-31$818.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,073Operating cash flow, Q2 FY2025, three months to 2025-06-30$1.07bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure1,241Operating cash flow, Q3 FY2025, three months to 2025-09-30$1.24bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure498Operating cash flow, Q4 FY2025, three months to 2025-12-31$498.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure1,428Operating cash flow, Q1 FY2026, three months to 2026-03-31$1.43bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure1,125Operating cash flow, Q2 FY2026, three months to 2026-06-30$1.13bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m40.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$40.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0000875320-24-000223. Derived: 9-month figure less the 6-month figure.Report this figure58.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$58.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure68.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$68.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure69.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$69.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000875320-25-000216. Derived: 6-month figure less the 3-month figure.Report this figure67.7Capital expenditure, Q3 FY2024, three months to 2024-09-30$67.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure92.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$92.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure40.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$40.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure146Capital expenditure, Q2 FY2025, three months to 2025-06-30$145.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure102Capital expenditure, Q3 FY2025, three months to 2025-09-30$101.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure149Capital expenditure, Q4 FY2025, three months to 2025-12-31$149.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure133Capital expenditure, Q1 FY2026, three months to 2026-03-31$133.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure112Capital expenditure, Q2 FY2026, three months to 2026-06-30$112.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m117Share repurchases, Q3 FY2023, three months to 2023-09-30$117.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-05, accession 0000875320-24-000223. Derived: 9-month figure less the 6-month figure.Report this figure150Share repurchases, Q4 FY2023, three months to 2023-12-31$149.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure131Share repurchases, Q1 FY2024, three months to 2024-03-31$131.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure320Share repurchases, Q2 FY2024, three months to 2024-06-30$320.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-05, accession 0000875320-25-000216. Derived: 6-month figure less the 3-month figure.Report this figure308Share repurchases, Q3 FY2024, three months to 2024-09-30$307.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure418Share repurchases, Q4 FY2024, three months to 2024-12-31$417.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure426Share repurchases, Q1 FY2025, three months to 2025-03-31$426.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure392Share repurchases, Q2 FY2025, three months to 2025-06-30$391.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure1,071Share repurchases, Q3 FY2025, three months to 2025-09-30$1.07bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0000875320-25-000232. Derived: 9-month figure less the 6-month figure.Report this figure128Share repurchases, Q4 FY2025, three months to 2025-12-31$128.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-13, accession 0000875320-26-000056. Derived: 12-month figure less the 9-month figure.Report this figure337Share repurchases, Q1 FY2026, three months to 2026-03-31$336.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure470Share repurchases, Q2 FY2026, three months to 2026-06-30$469.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-04, accession 0000875320-26-000259. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)255.20m, Q2 FY2026
Vertex Pharmaceuticals Inc / Ma, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares260Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30259,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000875320-23-000031.Report this figure260Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31260,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000875320-24-000139.Report this figure260Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30260,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0000875320-24-000198.Report this figure261Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30260,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0000875320-24-000223.Report this figure261Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31261,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000875320-25-000192.Report this figure258Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30258,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000875320-25-000216.Report this figure261Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30261,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure260Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31259,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure259Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30258,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure258Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30257,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0000875320-25-000232.Report this figure256Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31256,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000875320-26-000173.Report this figure255Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30255,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure

Shares outstanding: 253.46mShares outstanding, period not labelled, at 2026-07-31253,460,924 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0000875320-26-000259.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.